Healthcare & Pharmaceutical
Subscribe now
FOR THE LATEST ISSUE OF
BUSINESS FOCUS
Child Category
category
678faaf601348
0
0
4
Loading....
The teenage market is one of the most sought-after yet rapidly evolving audiences out there. So to sell to them, Indu went to the experts.
Comes to Europe with duo of exclusive five-night retreats at Weissenhaus, Germany
Pioneering transformative wellness destination Chiva-Som Hua Hin, Thailand, is set to bring a wellbeing premiere to the shores of the Baltic Sea with its first ever retreat residency in Germany, in partnership with acclaimed luxury resort, Weissenhaus.
Clinical Research Trailblazer: Interview with CEO Peter Ronco
US-headquartered Emmes, a specialty Clinical Research Organization, is combining its medical research legacy with the latest technological developments to build a clinical research infrastructure for the future.
Committed to Health and Innovation
Spain-based Suanfarma, a leading manufacturer and distributor of active pharmaceutical ingredients, is at the core of a better life.
Evolving the Value Chain: Interview with Guido D’Agostino, Head of Global Procurement
Chiesi Group has set out on a strategic path that will see a progressive increase in the level of sustainability across the whole Chiesi ecosystem of partners and suppliers.
WINS BEST PERFORMING LARGE COMPANY AWARD FROM SDA BOCCONI
F.I.S. - Fabbrica Italiana Sintetici, a leading company in the Italian pharmaceutical sector and one of the main European players in the production of active ingredients for the pharmaceutical industry, is pleased to announce that it has been awarded the prestigious Best Performing Large Company Award by SDA Bocconi - School of Management.
Partners with UK rapid test developer Abingdon Health to develop plastic free lateral flow test housing
A Medical Merger: Interview with GZA Ziekenhuize CEO, Willeke Dijkhoffz & ZNA CEO, Eddy Aerts.
Backed initiative in personalized medicine and diagnostics secures a SEK 12 million boost from KK-stiftelsen
A Place for Innovation: Interview with Giorgio Bertolini, Vice President for Research & Development
